Loading...
BROWN AND BURK LIMITED — Fluoxetine Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #3 buyer for Fluoxetine · $697.2K import value · 26 shipments · UNITED KINGDOM · DGFT Verified
BROWN AND BURK LIMITED is the #3 importer of Fluoxetine from India with $697.2K in import value and 26 verified shipments. BROWN AND BURK LIMITED holds a 0.3% market share in Fluoxetine imports based in UNITED KINGDOM. The company sources from 1 verified supplier across 14 formulations shipped to 1 country. Overall, BROWN AND BURK LIMITED imports 3 pharmaceutical products worth $1.0M across 3 therapeutic categories.
Verified from 26 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MICRO LABS LIMITED | $697.2K | 26 | 100.0% |
BROWN AND BURK LIMITED sources Fluoxetine from 1 verified Indian supplier based on 26 customs records. The primary supplier is MICRO LABS LIMITED accounting for 100.0% of imports.
Buyers ranked immediately above and below #3 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | AVET PHARMACEUTICALS INC C/O | UNITED STATES | $800.0K | 16 | $50.0K |
| 14 | APOTEX PTY LTD | AUSTRALIA | $700.0K | 14 | $50.0K |
| 3 | BROWN AND BURK LIMITED ★ | UNITED KINGDOM | $600.0K | 12 | $50.0K |
BROWN AND BURK LIMITED ranks #3 among 522 Fluoxetine importers from India. Average shipment value of $50.0K compared to the market average of $41.4K. The closest competitors by value are AVET PHARMACEUTICALS INC C/O and APOTEX PTY LTD.
Destination countries from 26 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $697.2K | 26 | 100.0% |
BROWN AND BURK LIMITED imports Fluoxetine to 1 country. The primary destination is UNITED KINGDOM receiving 100.0% of shipments worth $697.2K.
| Formulation | Value | Shipments |
|---|---|---|
| FLUOXETINE 20MG CAPSULES (3X10s) - TAX I | $348.4K | 7 |
| FLUOXETINE 20MG CAPSULES 3X10s TAX I | $50.0K | 1 |
| FLUOXETINE 20MG CAPSULES 3X10s TAX INVOICE NO 701207126 DT 15 03 2023 | $50.0K | 1 |
| FLUOXETINE CAPSULES 20MG 3X10s - TAX I | $50.0K | 1 |
| FLUOXETINE CAPSULES 20MG (3X10s) - TAX INVOICE NO: 701210040 DT: 29.03.2025 | $50.0K | 1 |
| FLUOXETINE CAPSULES 20MG 3X10s TAX INVOICE NO 701210237 DT 24 05 2025 | $50.0K | 1 |
| FLUOXETINE CAPSULES 20MG 3X10s TAX INVOICE NO 701210236 DT 24 05 2025 | $50.0K | 1 |
| FLUOXETINE 60MG HARD CAPSULES (IN BB LIVERY) ( 3X10S ) | $14.4K | 1 |
What BROWN AND BURK LIMITED and other importers must comply with to import Fluoxetine from India
Medicines and Healthcare products Regulatory Agency (MHRA)
Marketing Authorisation via national procedure or Mutual Recognition. Post-Brexit, separate UK MA required independent of EU approval.
Typical timeline: 12–15 months for national procedure
UK GMP compliance; MHRA GMP inspection of manufacturing site
India exported $21.6M worth of Fluoxetine through 3,702 shipments from 253 suppliers to 101 countries, serving 522 buyers globally. BROWN AND BURK LIMITED imports $697.2K of this total, accounting for 0.3% of India's Fluoxetine exports with 26 shipments from UNITED KINGDOM. This is verified from 26 customs shipment records covering 14 distinct formulations.
BROWN AND BURK LIMITED's average Fluoxetine order value is $26.8K per consignment, based on 26 shipments totaling $697.2K. BROWN AND BURK LIMITED is based in UNITED KINGDOM and ranks #3 among all Fluoxetine importers from India by value. The company sources from 1 verified supplier in India.
BROWN AND BURK LIMITED sources Fluoxetine from 1 verified Indian supplier: MICRO LABS LIMITED ($697.2K, 100.0%). This is based on 26 customs records.
BROWN AND BURK LIMITED ranks #3 among 522 Fluoxetine importers from India with a 0.3% market share. The top 3 importers are TIME-CAP LABS, ($2.7M), J. KNIPPER & COMPANY ($2.6M), DR. REDDYS LABORATORIES, INC ($2.3M). BROWN AND BURK LIMITED processed 26 shipments from UNITED KINGDOM.
BROWN AND BURK LIMITED imports 3 products worth $1.0M. Beyond Fluoxetine, top products include Clarithromycin, Flucloxacillin. View the complete BROWN AND BURK LIMITED profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Fluoxetine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for BROWN AND BURK LIMITED's Fluoxetine imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
BROWN AND BURK LIMITED
Full Company Profile →
3 products · $1.0M total trade · 3 categories
| FLUOXETINE 30 MG HARD CAPSULES ( (FLUOXETINE CAPSULES BP 30MG)) (3X10`S) (QTY- 17731.000) (TAX NO. 706205266) |
| $13.6K |
| 1 |
| PHARMA : FLUOXETINE 40 MG HARD CAPSULESIN BB LIVERY FLUOXETINE 40 MG - 3x10'S | $12.1K | 1 |
BROWN AND BURK LIMITED imports 14 distinct Fluoxetine formulations from India. The top formulation is FLUOXETINE 20MG CAPSULES (3X10s) - TAX I with 7 shipments worth $348.4K.
Manufacturer/Importer Authorisation (MIA) from MHRA; Qualified Person release required
UK-specific labeling; English language PIL; UK Marketing Authorisation number
Note: Post-Brexit, EU GMP certificates no longer automatically valid — separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available MHRA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with MHRA or qualified regulatory affairs professionals for case-specific guidance.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 101+ countries, 522+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Verified from customs records
Access shipment-level records, supplier contacts, and formulation details for BROWN AND BURK LIMITED.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Fluoxetine. For current order-level data, contact TransData Nexus.